| 今开：0.0 | 昨收：15.25 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.53615457E8 |
淘沙见金2017-10-09 21:20
$Spark Therapeutics, Inc.(ONCE)$ 周四的专家委员会通过问题应该不大，希望 $Nightstar Therapeutics plc - American Depositary Shares(NITE)$ 也能沾点老大哥的光。Luxturna的定价会是关键，有报道称1 million 一例。 $Aerie Pharmaceuticals, Inc.(AERI)$ 周五也有专家委员会。生医经历了疯狂...查看全文
美股医药Z博士2017-10-03 15:45
$Aerie Pharmaceuticals, Inc.(AERI)$ 今天带点量涨了4%左右，10月13号会议决定新药是否审批，看好接下来两周行情。查看全文
淘沙见金2017-07-08 11:33
青光眼是常见的一种眼疾，成因之一就是眼内压间断或持续升高。持续的高眼压给眼球各部分组织带来损害，治疗不及时会导致失明。青光眼是一个非常大的市场，全球共有近7000万青光眼患者，预计到2020年，这一数字将上升为7960万。但是近20年，抗青光眼都没有什么新药推出，主要的原因在于现有的前列腺...查看全文
割资本主义羊毛2015-09-17 20:37
$AERIE PHARMACEUTICALS INC(AERI)$ After the trial failed in April, Aerie made its case to the FDA, and the agency agreed in June to change the primary goal for its coming study. That put Aerie’s assertions to the test. Today, Aerie claims its assertion has paid off with posi...查看全文
割资本主义羊毛2015-09-17 20:00
$AERIE PHARMACEUTICALS INC(AERI)$ 目前公司账面已经几乎没有现金，盘前数据利好在公司现金流困难和竞争对手$INOTEK PHARMACEUTICALS CORP(ITEK)$ 先手数据利好下，注意前期套牢盘解套的窗口期，itek上获益颇丰的玩家对此也需谨慎。查看全文
木月皿2015-07-28 21:28
$AERIE PHARMACEUTICALS INC(AERI)$ FDA同意降低Rhopressa第二项Ph3的主要终点。从第一项Ph3的数据来看，按照该标准，本季度第二项Ph3达到主要终点的可能性很大，但是次要终点（<27mmHg）估计很难达到。该公司的核心产品还是Roclatan，Q3开始Ph3试验。虽然ITEK的Trabodenoson极具竞争力，但从时...查看全文
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058186 Size: 10 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058188 Size: 8 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058189 Size: 12 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058191 Size: 10 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058183 Size: 8 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058176 Size: 12 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058180 Size: 8 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058172 Size: 10 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058165 Size: 12 KB 网页链接
$Aerie医药(AERI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-058154 Size: 10 KB 网页链接